← Back
Data updated: Mar 10, 2026
NOSTRUM PHARMS LLC
Pharmaceuticals
NOSTRUM PHARMS LLC is a generic drug manufacturer with 3 FDA-approved products.
1983
Since
3
Drugs
-
Trials
44
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
METFORMIN HYDROCHLORIDE 2025-11-10
Manufacturing (CMC)
VENLAFAXINE HYDROCHLORIDE 2025-09-17
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-09-02
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-09-02
Labeling
METFORMIN HYDROCHLORIDE 2025-06-24
Labeling
METFORMIN HYDROCHLORIDE 2025-06-24
Labeling
THEOPHYLLINE 2025-06-13
Labeling
THEOPHYLLINE 2025-06-13
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-04-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (2)
Company Info
- First Approval
- 1983-01-11
- Latest
- 2023-08-09
- Applications
- 3